Madrigal Pharmaceuticals is…
Madrigal Pharmaceuticals is continuing to splash the cash this year [...]
A phase 2 asthma study of Upstream…
A phase 2 asthma study of Upstream Bio’s TSLP receptor [...]
I Just Returned From China. We Are Not Winning.
If we are going to be competitive with China, we [...]
The FDA specifically took issue…
The FDA specifically took issue with the trial’s control arm, [...]
PharmaEssentia will spend $46…
PharmaEssentia will spend $46 million to build a manufacturing facility [...]
With Incyte set to lose patent…
With Incyte set to lose patent protection for its blood [...]
Nektar Therapeutics is basking in…
Nektar Therapeutics is basking in the honeyed glow of long-term [...]
Evommune has aced its first major…
Evommune has aced its first major test as a public [...]
AstraZeneca is taking its oral…
AstraZeneca is taking its oral GLP-1 drug into phase 3 [...]
A new campaign from Otsuka aims to…
A new campaign from Otsuka aims to educate healthcare professionals [...]